The Oncology Institute, Inc.

The Oncology Institute, Inc.

STLN · NASDAQ · Healthcare / Medical Care Facilities

3.50USD-0.25 (-6.67%)

Price History

Full chart

Market Stats

Previous Close3.75
Open3.76
Day Range3.30 – 3.78
52-Week Range2.32 – 7.13
Volume22.22M
Market Cap678.76M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.29
Dividend Yield0.00%
Beta0.44
50-Day Avg5.98
200-Day Avg4.32

About

Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company offers physician services, in-house infusion, in-house specialty pharmacy, clinical trials, radiation therapy, and outpatient blood product transfusion services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance and support services. It also manages clinical trials and palliative care programs; operates combined community clinics and infusion suites; and operates a specialty pharmacy that includes both in-office and mail-order dispensing for complementary oral and self-injectable medications taken by patients concurrent with their in-office cancer therapies. It serves adult and senior cancer patients. The company was formerly known as The Oncology Institute, Inc. and changed its name to Starling Oncology, Inc. in August 2026. Starling Oncology, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEODr. Daniel Virnich FACHE, M.B.A., M.D.
  • Employees641
  • Headquarters18000 Studebaker Road, Cerritos, CA, United States, 90703, USA
  • Websitehttps://starlingoncology.com

Leadership

  • Dr. Daniel Virnich FACHE, M.B.A., M.D.CEO & Executive Director · b. 1979
  • Mr. Robert CarterChief Financial Officer · b. 1986
  • Dr. Yale D. Podnos F.A.C.S., M.D., M.P.H.Chief Medical Officer · b. 1972
  • Mr. Austin LeeVP of Accounting & Controller
  • Mr. Rakesh PandaChief Information Officer
  • Ms. Minh MerchantChief Legal Officer · b. 1973
  • Mr. Nolan MarianoChief People Officer
  • Mr. Mark Hueppelsheuser Esq.General Counsel
  • Mr. Jordan McInerneyChief Development Officer
  • Mr. Stephen CellaSenior Vice President of Finance

Financials

Income Statement

Currency: USD2022-12-312023-12-312024-12-312025-12-31
Total Revenue252.48M324.24M393.41M502.73M
Growth (%)-+28.42%+21.33%+27.79%
Cost of Revenue200.39M264.67M339.42M426.29M
Gross Profit52.09M59.57M54.00M76.44M
Gross Margin20.63%18.37%13.73%15.20%
Operating Expense124.10M119.72M114.11M112.52M
Operating Income-72.01M-60.15M-60.12M-36.08M
Operating Margin-28.52%-18.55%-15.28%-7.18%
EBITDA8.40M-70.45M-50.88M-42.52M
EBITDA Margin3.33%-21.73%-12.93%-8.46%
Net Income152.00K-83.07M-64.66M-60.61M
Net Income Margin0.06%-25.62%-16.44%-12.06%
Interest Expense4.08M6.78M7.50M11.28M
Interest Expense % of Total Revenue1.62%2.09%1.91%2.24%

Balance Sheet

Currency: USD2022-12-312023-12-312024-12-312025-12-31
Total Assets261.67M209.24M172.72M164.66M
Total Liabilities138.49M152.22M169.13M180.38M
Total Equity123.17M57.02M3.59M-15.72M
Cash14.01M33.49M49.67M33.56M
Total Debt---103.69M
Net Debt66.61M53.34M43.46M70.12M

Cash Flow

Currency: USD2022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-61.76M-36.31M-26.54M-24.59M
Investing Cash Flow----3.07M
Financing Cash Flow92.21M-6.85M-3.49M11.56M
Capital Expenditure5.53M4.57M3.79M3.20M
Free Cash Flow-67.28M-40.88M-30.33M-27.79M
FCF to OCF108.95%112.58%114.28%113.02%

Earnings

Report DateJun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Mar 11, 2022Jun 1, 2022Aug 10, 2022Nov 10, 2022Mar 10, 2023May 11, 2023Aug 9, 2023Nov 9, 2023Mar 28, 2024May 15, 2024Aug 14, 2024Nov 14, 2024Mar 24, 2025May 15, 2025Aug 14, 2025Nov 14, 2025Mar 13, 2026May 8, 2026Aug 6, 2026Nov 12, 2026
EPS Estimate---------------------0.12-0.11-0.09-0.09-0.07-0.07
EPS Actual-0.00-0.00-0.280.20-0.21-0.01-0.150.25-0.06-0.17-0.15-0.33-0.19-0.19-0.21-0.22-0.17-0.18-0.14-0.21-0.15-0.14-0.06-0.02-0.08-
Surprise---------------------25.00%-23.57%33.33%77.14%-14.29%-
Timing------------------------After-hours-

Key Statistics & Ratios

Market Cap678.76M
Enterprise Value758.96M
Trailing P/E0.00
Forward P/E0.00
Price / Sales1.16
Price / Book0.76
EPS-0.29
Book Value-0.248
Revenue (TTM)587.24M
Gross Profit (TTM)92.17M
EBITDA-19.28M
Profit Margin-6.18%
Operating Margin-2.86%
Return on Equity0.00%
Return on Assets-9.65%
Shares Outstanding101.92M
Shares Float88.89M
Beta0.44
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
46.81%
Insiders
17.79%
Retail / Other
35.40%

Top Institutional Holders

  • BlackRock Inc
    4.42M4.33%
  • Vanguard Capital Management, LLC
    3.48M3.41%
  • Deerfield Management Co
    3.36M3.30%
  • JOSH ARNOLD INVESTMENT CONSULTANT, LLC
    2.46M2.42%
  • Balyasny Asset Management LLC
    1.83M1.79%
  • Geode Capital Management, LLC
    1.76M1.72%
  • Wexford Capital LP
    1.71M1.68%
  • State Street Corp
    1.46M1.43%
  • The Goldman Sachs Group Inc
    1.35M1.33%
  • CenterBook Partners LP
    1.24M1.22%
  • BRC Group Holdings Inc
    929.73K0.91%
  • Renaissance Technologies Corp
    902.81K0.89%
  • Citadel Advisors Llc
    894.10K0.88%
  • Vanguard Portfolio Management, LLC
    862.84K0.85%
  • Two Sigma Investments LLC
    668.84K0.66%
  • Ensign Peak Advisors Inc
    626.85K0.62%

Top Fund Holders

  • Vanguard MStar Total Stk Mkt Idx Invest
    2.40M2.35%
  • iShares Russell 2000 ETF
    1.97M1.93%
  • Nuveen Quant Small Cap Equity R6
    1.03M1.01%
  • Fidelity Small Cap Index
    829.83K0.81%